Geneos Wealth Management’s Invesco S&P MidCap 400 Pure Value ETF RFV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$726K Buy
5,080
+397
+8% +$55.3K 0.01% 619
2026
Q1
$609K Buy
4,683
+2,877
+159% +$383K 0.01% 630
2025
Q4
$231K Buy
1,806
+1,713
+1,842% +$219K 0.01% 885
2025
Q3
$11.9K Hold
93
﹤0.01% 1904
2025
Q2
$11.2K Hold
93
﹤0.01% 2274
2025
Q1
$10.6K Hold
93
﹤0.01% 2228
2024
Q4
$11.3K Hold
93
﹤0.01% 2004
2024
Q3
$11K Sell
93
-300
-76% -$34.3K ﹤0.01% 1804
2024
Q2
$43.9K Hold
393
﹤0.01% 1109
2024
Q1
$46.9K Hold
393
﹤0.01% 1086
2023
Q4
$45.8K Hold
393
﹤0.01% 1096
2023
Q3
$38.7K Buy
393
+93
+31% +$9.63K ﹤0.01% 1154
2023
Q2
$31K Hold
300
﹤0.01% 1235
2023
Q1
$28.3K Hold
300
﹤0.01% 1241
2022
Q4
$27.2K Hold
300
﹤0.01% 1246
2022
Q3
$23K Hold
300
﹤0.01% 1275
2022
Q2
$25K Hold
300
﹤0.01% 1592
2022
Q1
$28K Buy
+300
New +$28.7K ﹤0.01% 1641

Other funds holding RFV

Geneos Wealth Management's RFV Position: Q2 2026 in Review

Geneos Wealth Management increased its Invesco S&P MidCap 400 Pure Value ETF (RFV) stake by 8.5% in Q2 2026, buying an estimated $55.3K and bringing the position to 5,080 shares worth $726K. The position accounts for 0.01% of the portfolio, ranked #619.

Geneos Wealth Management first reported a position in RFV in Q1 2022 and has held it in 18 quarters since. 95 funds tracked by Wall St. Rank hold RFV as of Q2 2026.

  • Geneos Wealth Management held 5,080 shares of Invesco S&P MidCap 400 Pure Value ETF worth $726K as of Q2 2026.
  • Geneos Wealth Management bought 397 Invesco S&P MidCap 400 Pure Value ETF shares in Q2 2026, an estimated $55.3K.
  • Invesco S&P MidCap 400 Pure Value ETF made up 0.01% of Geneos Wealth Management's portfolio in Q2 2026, its #619 holding.
  • Geneos Wealth Management first reported a position in Invesco S&P MidCap 400 Pure Value ETF in Q1 2022 and has held it in 18 quarters since.
  • 95 funds tracked by Wall St. Rank held Invesco S&P MidCap 400 Pure Value ETF as of Q2 2026.

Based on Geneos Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.